November 2025 has been a busy month for healthtech startups, with several promising ones raising substantial capital across AI, diagnostics, BCI, digital care, femtech, and more.
Here’s a snapshot of the major healthtech and biotech funding announcements from the month:
Synchron
Funds raised: US $308 million
Round: Series D
Investors: Double Point Ventures (lead); NRF (AUD 54M); ARCH Ventures; Khosla Ventures; Bezos Expeditions; NTI; METIS
About the startup: Synchron is a minimally invasive brain-computer interface (BCI) company developing the Stentrode, an implant that lets people with paralysis control digital devices using their thoughts.
How it plans to use the funds: Complete clinical trials, accelerate commercialization, and develop next-generation neural interface hardware.
RAGE Biotech
Funds raised: US $29 million
Round: Series A
Investors: Led by IP Group Australia and Hostplus; Monash Ventures also participated.
About the startup: RAGE Biotech is a therapeutics company developing inhaled splice-switching oligonucleotide (SSO) therapies to treat chronic lung diseases (e.g., COPD and inflammatory lung conditions).
How it plans to use the funds: Advance its lead therapy (RB042) into first-in-human clinical trials, and support development of its broader pipeline targeting other respiratory and non-respiratory diseases.
Coherence Neuro
Funds raised: US $10 million
Round: Seed round
Investors: Led by Artesian (Alternative Investments) & Topology Ventures; Blackbird Ventures, Possible Ventures, XEIA Venture Partners, Jumpspace Ventures, Spacewalk VC, and several angels/early-stage backers.
About the startup: Coherence Neuro is a neurotech company developing a brain-computer interface (BCI)-based device called SOMA-1, which monitors and treats cancer using targeted electrical stimulation.
How it plans to use the funds: Support the company’s first-in-human trials and advance its closed-loop neurotherapy platform for cancer treatment.
Hippocratic AI
Funds raised: US $126 million
Round: Series C
Investors: Led by Avenir Growth. Other participants: CapitalG (Google’s growth fund), General Catalyst, Andreessen Horowitz (a16z), Kleiner Perkins, Premji Invest, Universal Health Services (UHS), Cincinnati Children’s Hospital Medical Center, WellSpan Health, and others.
About the startup: Hippocratic AI builds generative‑AI “agents” for healthcare that handle non‑diagnostic, patient‑facing tasks, like appointment scheduling, patient intake, chronic‑care follow‑ups, and administrative support.
How it plans to use the funds:Scale deployments, expand customer base, enhance safety architecture, innovate products, and pursue strategic M&A.
Emm
Funds raised: US $9 million
Round: Seed
Investors: Led by Lunar Ventures; Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures, and angels.
About the startup: Emm is a UK-based femtech startup building a smart menstrual cup with sensors to track menstrual flow and provide cycle insights.
How it plans to use the funds: Launch the smart cup and companion app in the UK (2026), scale manufacturing, continue R&D, and prepare for U.S. market entry in 2027.
ImmunitoAI
Funds raised: US $6.1 million
Round: Series A
Investors: Led by Ashish Kacholia; pi Ventures, Anicut Capital, 3one4 Capital, and AC Ventures; JITO Incubation & Innovation Foundation, LVX, JJ Family Office, and angel investors.
About the startup: immunitoAI is a Bangalore‑based TechBio company that uses generative‑AI to design novel therapeutic antibodies from scratch, without relying on traditional biological antibody libraries. It aims to speed up and improve drug‑like antibody discovery.
How it plans to use the funds: Develop antibody therapeutics for identified disease targets and advance their pipeline toward preclinical validation.
Examedi
Funds raised: US $750,000
Round: — not explicitly labeled
Investors: Led by Platanus Ventures, with participation from existing board members; General Catalyst exited in this transaction.
About the startup: Examedi is a Latin‑American health‑tech platform that offers at‑home diagnostics and lab‑test services. Patients book tests online, and Examedi handles scheduling, sample collection, and returns results, skipping the need for in‑clinic visits.
How it plans to use the funds: Improve operational efficiency and expand its services in Mexico and Chile.
Morphle Labs
Funds raised: US $5 million
Round: Series A
Investors: Inflexor Ventures (lead)
About the startup: Morphle Labs is a Bengaluru‑based deep‑tech company developing robotic and AI‑powered systems, such as the robotic microtome (RoboTome) and high‑throughput slide scanner (MorphoLens), to automate critical steps in cancer diagnostics (histopathology).
How it plans to use the funds: Scale manufacturing, expand global reach, support regulatory approvals, grow team, deepen IP base.
Nest Health
Funds raised: US $22.5 million
Round: Series A
Investors: Socium Ventures; Amboy Street Ventures; Impact America Fund; Hopelab; University Growth Fund; Luminary Impact Fund. Socium Ventures will join the Nest Health board.
About the startup: Nest Health delivers comprehensive medical, behavioral, and social care directly to families on Medicaid through a mix of in‑home visits and virtual care. It covers primary care, mental health/substance‑use treatment, social support (housing, utilities, etc.), 24/7 clinical support, and care coordination.
How it plans to use the funds: Expand its family‑focused clinical offerings, scale geographically into new states, grow through payer partnerships, and deploy AI‑powered tools to automate administrative and care workflows.
Able Digital Wellness
Funds raised: US $400,000
Round: Seed
Investors: PLT (a Perth‑based venture capital firm)
About the startup: Able Digital Wellness offers a health and wellness tech platform tailored to individuals with disabilities and their caregivers. It delivers exercise, nutrition, sports, and mental‑wellbeing programs, plus tools for disability-service providers.
How it plans to use the funds: To expand and scale the platform and grow its B2B + B2C services.
Noteless
Funds raised: €3.5 million
Round: Seed round
Investors: Redstone (lead), Futurum Ventures and Farvatn Venture (continuing investors)
About the startup: Noteless is an AI‑powered health‑tech startup (based in Oslo) that automatically generates medical consultation notes in real time, turning doctor‑patient conversations into structured documentation to save time and reduce clinician burnout.
How it plans to use the funds: Expand adoption of its clinical documentation platform across Europe and scale its service to more clinicians and care settings.
Wrapping up
November 2025 highlighted the global momentum in healthtech, with startups across AI, biotech, diagnostics, digital care, and femtech raising significant capital.
Investors continue to back solutions that improve patient outcomes, streamline workflows, reduce clinician burden, and scale efficiently. These funding rounds set the stage for impactful innovation and growth in the months ahead.
